Pelargonidin

Found in Fragaria × ananassa (strawberries)
Evidence Level
Limited
3 Clinical Trials
5 Documented Benefits
2/5 Evidence Score

Anthocyanidin pigment giving strawberries, raspberries, red radishes, and pomegranate their distinctive red-orange color. Less studied than cyanidin or delphinidin in clinical context. Mostly preclinical evidence for anti-inflammatory and antioxidant activities. Strawberry RCTs (which deliver pelargonidin glycosides) provide indirect human evidence.

Studied Dose DIETARY INTAKE: 1-2 servings strawberries (~150 g) provides ~30-50 mg pelargonidin glycosides. STRAWBERRY RCTs: typically 250-500 g fresh strawberries OR equivalent freeze-dried strawberry powder (25-50 g) daily for 4-12 weeks. PURIFIED PELARGONIDIN: 50-200 mg/day in limited research contexts. Take with food (anthocyanins better absorbed with fat). NOTE: pelargonidin and other anthocyanins have notoriously POOR oral bioavailability (1-2% based on parent compound; metabolites may have biological effects). Anthocyanin metabolites (protocatechuic acid, phloroglucinaldehyde) circulate longer than parent compounds and may mediate clinical effects. Most human evidence is from whole fruit consumption rather than purified pelargonidin.
Active Compound Pelargonidin (3,5,7,4'-tetrahydroxyflavylium) — anthocyanidin aglycone. In foods exists as glycosides: pelargonidin-3-glucoside (P3G — most common), pelargonidin-3-rutinoside, pelargonidin-3,5-diglucoside

Benefits

Cardiovascular benefits via strawberry consumption

Strawberry consumption RCTs (delivering pelargonidin glycosides) show modest cardiovascular benefits: improved lipid profile, reduced LDL oxidation, improved endothelial function, modest BP reduction. Basu 2010 (PMID 20145018) and Burton-Freeman 2010 reviews documented strawberry effects in obese/metabolic syndrome subjects. Mechanism partially attributable to pelargonidin among other anthocyanins.

Anti-inflammatory effects (preclinical, strawberry RCTs)

Strawberry consumption reduces inflammatory markers (CRP, IL-6) in metabolic syndrome and obese subjects. Pelargonidin-rich foods generally show anti-inflammatory effects in human trials. Mechanism via NF-κB inhibition by anthocyanin metabolites.

Glucose metabolism (strawberry trials)

Some strawberry RCTs show improved postprandial glucose control and modest insulin sensitivity improvement. Pelargonidin-3-glucoside specifically shown to inhibit α-glucosidase. Mechanism for glycemic effects of strawberry-rich diets.

Antioxidant via metabolite effects

Pelargonidin and its metabolite protocatechuic acid demonstrate antioxidant activity in vitro and animal models. Strawberry consumption increases plasma antioxidant capacity. Mechanism for general 'oxidative stress reduction' claims associated with berry-rich diets.

Skin and UV protection (preclinical)

Animal studies show pelargonidin protects skin from UV-induced damage and may reduce photoaging markers. Mechanism: antioxidant + anti-inflammatory + collagen stabilization. Limited human RCT evidence specific to pelargonidin (vs other anthocyanins or topical anti-aging compounds).

Mechanism of action

1

Antioxidant via direct scavenging and Nrf2

Anthocyanidin structure (with hydroxyl groups + flavylium cation) provides direct radical scavenging. Plus activation of Nrf2 transcription factor upregulating endogenous antioxidant defenses. Mechanism for cellular oxidative stress reduction observed with strawberry consumption.

2

α-Glucosidase inhibition

Pelargonidin-3-glucoside inhibits intestinal α-glucosidase — slowing carbohydrate digestion and reducing postprandial glucose spikes. Mechanism similar to acarbose drug class. Contributes to glucose-modulating effects of berry consumption.

3

Metabolite-mediated activity (protocatechuic acid)

Pelargonidin is rapidly metabolized to protocatechuic acid (PCA) and phloroglucinaldehyde — these metabolites have longer plasma half-lives than parent anthocyanin and circulate at higher concentrations. May mediate the observed clinical effects more than parent pelargonidin itself. Reframes anthocyanin activity as 'metabolite delivery.'

4

Endothelial nitric oxide enhancement

Anthocyanins generally enhance endothelial nitric oxide synthase (eNOS) activity and bioavailability. Mechanism for improved endothelial function and modest BP-lowering effects in clinical trials.

5

NF-κB inhibition and anti-inflammatory cytokine reduction

Pelargonidin and metabolites inhibit NF-κB activation, reducing pro-inflammatory cytokines (TNF-α, IL-6, IL-1β). Mechanism for inflammation reduction in human trials of strawberry-rich diets.

Clinical trials

1
Basu 2010 — Strawberries in Metabolic Syndrome
PubMed

Strawberry RCT (Basu A, Wilkinson M, Penugonda K, Simmons B, Betts NM, Lyons TJ 2010, Nutr J 9:21, doi:10.1186/1475-2891-9-21, PMID 20492705).

27 women with metabolic syndrome consumed 50 g freeze-dried strawberries (≈3 cups fresh, providing ~145 mg pelargonidin glycosides + other anthocyanins) daily for 4 weeks. Cardiovascular biomarkers measured.

Reduced total cholesterol (-5%) and LDL cholesterol (-6%); reduced lipid peroxidation markers; improved blood pressure modestly. NO change in HDL or triglycerides. Demonstrates pelargonidin-rich strawberry consumption has measurable cardiovascular biomarker effects in metabolic syndrome population. Limited by single-center, small sample, no placebo control.

2
Burton-Freeman 2010 — Strawberry Postprandial Effects
PubMed

Postprandial RCT (Burton-Freeman B, Linares A, Hyson D, Kappagoda T 2010, J Am Coll Nutr 29(1):46-54, doi:10.1080/07315724.2010.10719816, PMID 20595645).

24 obese hyperlipidemic adults consumed strawberry beverage (10 g freeze-dried strawberries) or placebo with high-fat/carbohydrate test meal. Postprandial inflammatory and oxidative response measured.

Strawberry beverage REDUCED postprandial inflammatory response (IL-6, IL-1β) and oxidative stress markers vs placebo. Demonstrates acute effects of pelargonidin-rich strawberry on postprandial inflammation in metabolically vulnerable population. Supports inclusion of strawberries in mixed meals to reduce postprandial inflammatory spike.

3
Tulipani 2014 — Strawberry Anthocyanins Bioavailability
PubMed

Bioavailability study (Tulipani S, Mora-Cubillos X, Jáuregui O, Llorach R, García-Aloy M, Covas MI, Andres-Lacueva C 2014, J Agric Food Chem 62(15):3441-3452, doi:10.1021/jf500449w, PMID 24579822).

Healthy volunteers consumed strawberry pulp; plasma and urinary anthocyanin metabolites measured by LC-MS/MS.

Pelargonidin-3-glucoside is the major anthocyanin from strawberry; rapidly metabolized to protocatechuic acid, phloroglucinaldehyde, and other metabolites that circulate longer than parent compound. Bioavailability of parent pelargonidin extremely low (~1-2%) but metabolite-mediated activity may be biologically important. Important context for understanding human pharmacology.

About this ingredient

About the active ingredient

Pelargonidin (3,5,7,4'-tetrahydroxyflavylium chloride) is one of the six common anthocyanidin aglycones found in plant foods (alongside cyanidin, delphinidin, peonidin, petunidin, malvidin). Named after the Pelargonium genus where it was first identified. Pelargonidin is distinctively associated with RED-ORANGE pigmentation — versus cyanidin (red-purple) and delphinidin (blue-purple).

DIETARY SOURCES: STRAWBERRIES (Fragaria × ananassa) — the dominant pelargonidin source; pelargonidin-3-glucoside (P3G) is the major strawberry anthocyanin. Other sources: RASPBERRIES (red), red radishes, pomegranate arils, red kidney beans, pinto beans (provide some pelargonidin alongside other anthocyanins). In food matrices, pelargonidin exists as GLYCOSIDES (pelargonidin-3-glucoside being most common; also pelargonidin-3-rutinoside, pelargonidin-3,5-diglucoside).

PHARMACOKINETICS are characteristic of anthocyanins generally: poor oral bioavailability of parent compound (~1-2%) due to instability at neutral pH and rapid Phase 2 metabolism. RAPID METABOLITE FORMATION is critical — pelargonidin is converted to PROTOCATECHUIC ACID (PCA), phloroglucinaldehyde, and other small phenolic metabolites. These metabolites have longer plasma half-lives than parent pelargonidin and may mediate biological effects.

Modern anthocyanin pharmacology research focuses on metabolite-mediated activity rather than parent compound effects. EVIDENCE: 2/5 reflects: (1) Multiple strawberry RCTs (Basu 2010 PMID 20492705 metabolic syndrome, Burton-Freeman 2010 PMID 20595645 postprandial) showing cardiovascular and inflammatory benefits — but cannot fully attribute to pelargonidin alone vs whole-strawberry effects, (2) Tulipani 2014 PMID 24579822 bioavailability characterization, (3) extensive preclinical evidence for antioxidant, anti-inflammatory, glucose-modulating effects, (4) MAJOR LIMITATION: virtually no rigorous human RCTs of purified pelargonidin supplements (vs strawberry consumption). The whole-food evidence base is reasonable; the isolated supplement evidence is minimal.

SAFETY: Excellent at dietary intakes; pharmacological supplementation insufficient data. Best positioned as: (a) marker for strawberry/raspberry consumption (where whole-food evidence supports cardiovascular and metabolic benefits), (b) component of a colorful fruit-rich diet — pelargonidin gives strawberries their color and contributes to but doesn't fully explain strawberry health effects, (c) NOT recommended as isolated supplement due to absence of human pharmacological data, (d) part of broader anthocyanin family with complementary actions to cyanidin (in tart cherries/black raspberries), delphinidin (in blueberries/blackcurrants), etc. Honest framing: pelargonidin is essentially a strawberry biomarker — eat strawberries for their evidence-based cardiovascular and metabolic benefits rather than purified pelargonidin supplements.

The whole-food matrix delivers a complete anthocyanin/polyphenol package that purified single-compound supplements cannot replicate.

Side effects and drug interactions

Common Potential side effects

Generally well-tolerated as part of normal fruit consumption.
Mild GI upset at very high anthocyanin doses (purified extracts).
Allergic reactions: occasional strawberry allergy (oral allergy syndrome).
Pregnancy/lactation: dietary intake safe; pharmacological supplementation insufficient data.
Theoretical mild antiplatelet activity at high doses.

Important Drug interactions

Generally minimal interactions at dietary intakes.
Theoretical mild bleeding risk with anticoagulants at high purified doses.
CYP enzyme effects: in vitro inhibition; clinical relevance limited at typical doses.
Compatible with most medications.
No major clinically documented interactions.

Frequently asked questions about Pelargonidin

What is the recommended dosage of Pelargonidin?

The clinically studied dose for Pelargonidin is DIETARY INTAKE: 1-2 servings strawberries (~150 g) provides ~30-50 mg pelargonidin glycosides. STRAWBERRY RCTs: typically 250-500 g fresh strawberries OR equivalent freeze-dried strawberry powder (25-50 g) daily for 4-12 weeks. PURIFIED PELARGONIDIN: 50-200 mg/day in limited research contexts. Take with food (anthocyanins better absorbed with fat). NOTE: pelargonidin and other anthocyanins have notoriously POOR oral bioavailability (1-2% based on parent compound; metabolites may have biological effects). Anthocyanin metabolites (protocatechuic acid, phloroglucinaldehyde) circulate longer than parent compounds and may mediate clinical effects. Most human evidence is from whole fruit consumption rather than purified pelargonidin.. Always follow product labeling and consult a healthcare provider for personalized dosing recommendations.

What is Pelargonidin used for?

Pelargonidin is studied for cardiovascular benefits via strawberry consumption, anti-inflammatory effects (preclinical, strawberry rcts), glucose metabolism (strawberry trials). Strawberry consumption RCTs (delivering pelargonidin glycosides) show modest cardiovascular benefits: improved lipid profile, reduced LDL oxidation, improved endothelial function, modest BP reduction.

Are there side effects from taking Pelargonidin?

Reported potential side effects may include: Generally well-tolerated as part of normal fruit consumption. Mild GI upset at very high anthocyanin doses (purified extracts). Always consult a healthcare provider before starting any new supplement, especially if you have underlying conditions or take medications.

Does Pelargonidin interact with medications?

Known drug interactions may include: Generally minimal interactions at dietary intakes. Theoretical mild bleeding risk with anticoagulants at high purified doses. Consult a pharmacist or healthcare provider if you take prescription medications.

Is Pelargonidin good for antioxidant?

Yes, Pelargonidin is researched for Antioxidant support. Pelargonidin and its metabolite protocatechuic acid demonstrate antioxidant activity in vitro and animal models. Strawberry consumption increases plasma antioxidant capacity. Mechanism for general 'oxidative stress reduction' claims associated with berry-rich diets.